X4 Pharmaceuticals (XFOR) Earnings Date & Reports

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XFOR is expected to report earnings to fall 40.85% to -11 cents per share on May 08

X4 Pharmaceuticals XFOR Stock Earnings Reports

Q1'25

Est.

$-0.12

Q4'24

Missed

by $0.04

Q3'24

Missed

by $0.01

Q2'24

Beat

by $0.46

Q1'24

Missed

by $0.12

The last earnings report on March 25 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 702.93K shares outstanding, the current market capitalization sits at 40.29M.

View a ticker or compare two or three

Compare

XFOR